NEW Wilsons Research & Valuation Report
Wilsons Equity Research has released its latest research and valuation report on Anatara Lifesciences (ANR). The report maintained a BUY rating and a price target of $1.66 per share.
“Still have our nose in this little trough”
Please open the attached PDF to view the report.